FDA LISTING INC: EXPERIENCED ADVISORS FOR FULL-SERVICE FDA REGISTRATION & COMPLIANCE
+1 212 444 8202
FDA First Aid Antibiotic Monograph M004 outlines conditions that may apply to over-the-counter first-aid antibiotic drug products marketed in the United States, including permitted active ingredients, ingredient combinations, labeling, directions, warnings, and related compliance requirements.
First-aid antibiotic products are OTC drug products intended to help prevent infection in minor cuts, scrapes, and burns. FDA Monograph M004 covers certain topical antibiotic products, including ointments, creams, and similar topical dosage forms.
For brand owners, importers, private-label companies, and manufacturers, key compliance considerations include the active ingredient and strength, intended use, dosage form, permitted ingredient combinations, Drug Facts labeling, required warnings, directions for use, and FDA drug establishment registration and drug-listing requirements.
FDA Monograph M004 may apply to first-aid antibiotic ointments, topical antibiotic creams, bacitracin products, neomycin products, polymyxin B products, double-antibiotic products, triple-antibiotic products, and similar topical products marketed to help prevent infection in minor cuts, scrapes, and burns.
The product format alone does not determine whether a product fits the monograph. Also review the active ingredient, strength, intended use, dosage form, directions for use, warning statements, ingredient combinations, and labeling claims. A product’s claims should match the applicable active ingredient conditions and the finished formulation.
Products marketed to treat active infections, infected wounds, acne, burns beyond minor burns, chronic wounds, surgical wounds, eye infections, ear infections, fungal infections, or other conditions may fall under a different FDA regulatory framework. A first-aid antibiotic product should not use claims that exceed its applicable M004 conditions.
| Active Ingredient | Strength | Common Product Terms |
|---|---|---|
| Bacitracin | 500 units per gram in a suitable ointment base | Bacitracin ointment, first-aid antibiotic ointment |
| Bacitracin zinc | 500 units per gram in a suitable ointment base | Bacitracin zinc ointment, topical antibiotic ointment |
| Neomycin sulfate | Equivalent to 3.5 milligrams of neomycin per gram | Neomycin ointment, antibiotic cream, topical antibiotic |
| Polymyxin B sulfate | 5,000 units per gram | Polymyxin B ointment, topical antibiotic product |
| Chlortetracycline hydrochloride | 30 milligrams per gram in a suitable ointment base | First-aid antibiotic ointment |
| Tetracycline hydrochloride | 30 milligrams per gram in a suitable ointment base | First-aid antibiotic ointment |
FDA Monograph M004 includes specific active ingredient strengths, dosage-form requirements, permitted combinations, and labeling conditions. This table provides a simplified overview of common first-aid antibiotic ingredients and does not replace a review of the complete monograph.
FDA M004 includes specific permitted combinations of first-aid antibiotic active ingredients. Common examples include bacitracin or bacitracin zinc with polymyxin B sulfate, neomycin sulfate with polymyxin B sulfate, and triple-antibiotic combinations containing bacitracin or bacitracin zinc, neomycin sulfate, and polymyxin B sulfate. Each active ingredient must be present at the applicable strength, in the permitted dosage form, and with labeling that meets the relevant combination conditions.
Review first-aid antibiotic labeling as part of the finished product’s overall compliance position. Active ingredients, ingredient strengths, intended use, dosage form, Drug Facts content, warnings, directions, principal display panel statements, and online marketing should align with the product’s applicable conditions.
First-aid antibiotic claims should match the active ingredient, strength, intended use, and finished product dosage form. Products covered by M004 may be marketed for first aid to help prevent infection in minor cuts, scrapes, and burns.
A product should not use broader claims for treating infections, healing wounds, treating acne, treating surgical wounds, treating burns beyond minor burns, or treating other diseases unless those claims are supported through an appropriate regulatory pathway. Claims on packaging, e-commerce listings, retailer descriptions, websites, social media, and advertising should remain consistent with the Drug Facts panel.
The Drug Facts panel should identify each active ingredient and its strength, together with the corresponding purpose. The product name, front-label claims, and terms such as “first aid antibiotic,” “antibiotic ointment,” “double antibiotic,” or “triple antibiotic” should match the product’s active ingredients and permitted intended use.
If a first-aid antibiotic product contains more than one active ingredient, review the formulation and labeling for applicable combination conditions. Do not assume that separately permitted antibiotic active ingredients can be combined in any strength, dosage form, or claim combination.
First-aid antibiotic products generally require product-specific warning statements and directions. Depending on the active ingredient and finished product, warnings may address external use only, avoiding contact with eyes, not using over large areas of the body, discontinuing use if a rash or other allergic reaction develops, and consulting a doctor if the condition persists or worsens.
Products containing bacitracin, bacitracin zinc, neomycin, neomycin sulfate, polymyxin B, or polymyxin B sulfate should include the statement: “Do not use longer than 1 week unless directed by a doctor.”
Directions should match the active ingredient, product type, dosage form, frequency of use, and applicable age group. A typical first-aid antibiotic product may direct consumers to clean the affected area, apply a small amount one to three times daily, and cover the area with a sterile bandage if desired.
First-aid antibiotic products should include appropriate Drug Facts information, including active ingredients, purpose, uses, warnings, directions, and inactive ingredients. The Drug Facts panel should correspond to the finished product that is commercially distributed.
Review product names, antibiotic claims, infection-prevention claims, website content, retailer product descriptions, and advertising for consistency with the Drug Facts panel. Claims on ecommerce listings, social media, and other marketing materials should not expand the product’s permitted intended use.
This page provides a simplified overview of FDA OTC Monograph M004. It does not include every active ingredient, permitted combination, dosage-form requirement, testing requirement, labeling detail, warning, direction, or FDA administrative order that may apply to a specific first-aid antibiotic product.
For complete and current requirements, including active-ingredient conditions and administrative orders applicable to OTC first-aid antibiotic drug products, review the related official FDA monograph resource.
First-aid antibiotic compliance involves more than selecting an active ingredient. A product review may include active ingredients, ingredient strengths, intended use, dosage form, ingredient combinations, labeling claims, Drug Facts labeling, warnings, directions, manufacturing activities, and drug-listing information.
We assist with:
Need help with an FDA-regulated first-aid antibiotic product? Our team can assist with Drug Establishment Registration, OTC Drug Listing, NDC Labeler Codes, OTC Drug Label Review, and Drug Master Files.
_______ Related Services _______
_______ Related Services _______